Sagimet Biosciences Statistics
Total Valuation
SGMT has a market cap or net worth of $636.50 million. The enterprise value is $380.88 million.
| Market Cap | 636.50M |
| Enterprise Value | 380.88M |
Important Dates
The last earnings date was Tuesday, August 11, 2026, before market open.
| Earnings Date | Aug 11, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SGMT has 62.16 million shares outstanding. The number of shares has increased by 17.03% in one year.
| Current Share Class | 61.59M |
| Shares Outstanding | 62.16M |
| Shares Change (YoY) | +17.03% |
| Shares Change (QoQ) | +63.13% |
| Owned by Insiders (%) | 1.09% |
| Owned by Institutions (%) | 43.91% |
| Float | 59.41M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 2.24 |
| P/TBV Ratio | 2.45 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 45.02, with a Debt / Equity ratio of 0.01.
| Current Ratio | 45.02 |
| Quick Ratio | 44.31 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -24.37% and return on invested capital (ROIC) is -16.94%.
| Return on Equity (ROE) | -24.37% |
| Return on Assets (ROA) | -16.41% |
| Return on Invested Capital (ROIC) | -16.94% |
| Return on Capital Employed (ROCE) | -20.40% |
| Weighted Average Cost of Capital (WACC) | 22.87% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.94M |
| Employee Count | 16 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +5.64% in the last 52 weeks. The beta is 3.40, so SGMT's price volatility has been higher than the market average.
| Beta (5Y) | 3.40 |
| 52-Week Price Change | +5.64% |
| 50-Day Moving Average | 7.50 |
| 200-Day Moving Average | 6.64 |
| Relative Strength Index (RSI) | 75.39 |
| Average Volume (20 Days) | 1,137,498 |
Short Selling Information
The latest short interest is 11.60 million, so 18.65% of the outstanding shares have been sold short.
| Short Interest | 11.60M |
| Short Previous Month | 9.74M |
| Short % of Shares Out | 18.65% |
| Short % of Float | 19.52% |
| Short Ratio (days to cover) | 13.08 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -52.63M |
| Pretax Income | -47.08M |
| Net Income | -47.08M |
| EBITDA | n/a |
| EBIT | -52.63M |
| Earnings Per Share (EPS) | -$1.25 |
Balance Sheet
The company has $240.13 million in cash and $1.94 million in debt, with a net cash position of $255.62 million or $4.11 per share.
| Cash & Cash Equivalents | 240.13M |
| Total Debt | 1.94M |
| Net Cash | 255.62M |
| Net Cash Per Share | $4.11 |
| Equity (Book Value) | 256.16M |
| Book Value Per Share | 4.15 |
| Working Capital | 238.57M |
Cash Flow
| Operating Cash Flow | -41.72M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | n/a |
| Free Cash Flow | -41.72M |
| FCF Per Share | -$0.67 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
SGMT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -17.03% |
| Shareholder Yield | -17.03% |
| Earnings Yield | -7.49% |
| FCF Yield | -6.64% |
Analyst Forecast
The average price target for SGMT is $28.60, which is 179.30% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $28.60 |
| Price Target Difference | 179.30% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 10 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |